Precision Medicine in Inflammatory Bowel Disease

Purpose and goal

In Sweden, approximately 85,000 people live with inflammatory bowel disease (IBD). These chronic diseases are complex, with significant individual variations. The aim of the project is to improve treatment for people with IBD by developing and implementing precision medicine tools. By stimulating collaboration, the following effects are expected to be achieved: Increased quality of life for people with IBD Greater uptake of research results Increased use of precision medicine through interdisciplinary solutions and research project

Expected effects and result

The project is expected to result in an increased understanding of which biomarkers can identify high-risk patients, improved diagnostics, and personalized treatment at the individual level. The goal is to establish an internationally recognized and sustainable innovation environment that contributes to more efficient, person-centered care for IBD. This fills an important gap in Sweden, where there is a lack of centers focused on precision medicine for IBD.

Planned approach and implementation

By working in parallel with research project on treatment response, and tools for transcriptomics in IBD, the project will to contribute to solving problems in clinical practice while accelerating the development and improvement of IBD treatment through its shared, open innovation environment The collaboration is led by a steering committee that ensures the quality and relevance of the innovation environment. During the project, the innovation environment can be expanded with additional partners.